Ireland· IE-PA-PA1638/001/001
Betnesol 0.1% w/v Eye, Ear and Nasal Drops, solution
A betamethasone product containing betamethasone sodium phosphate, registered in Ireland by RPH Pharmaceuticals AB. The same ATC class is registered in 2 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Betamethasone is registered in 2 of 19 countries.
Countries holding a registration under ATC S02BA07 (betamethasone), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 1 of them publish a price we can compare per daily dose
Betamethasone · ATC S02BA07
2 / 19 countries
- Ireland
- Norwayprice
The record
At a glance
HPRA (Ireland)- Active substance
- BETAMETHASONE SODIUM PHOSPHATE
- Manufacturer
- RPH Pharmaceuticals AB
- Country
- Ireland (IE)
- ATC code
- S02BA07
- ATC class
- Betamethasone
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA1638/001/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Betamethasone in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumBetnesol 0.5 mgAlfasigma
- GermanyCelestan SolubileOrganonhealthcare Gmbh
- FinlandBetapredALFASIGMA S.p.A.
- NorwayBentelanAlfasigma
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Austria · Solu - Celestan
- Belgium · Celestone
- Germany · Celestan Solubile
- France · Betamethasone Basi, Betnesol
- United Kingdom (Northern Ireland) · Betamethasone Martindale Pharmaceuticals, Betamethasone Morningside Healthcare
- Italy · Albaflo, Bentelan
- Poland · Celestone
- Romania · Ophtamesone
- Sweden · Betapred
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0e6176a6-ff23-42fd-b998-4039bbbf7691 GET /v1/drugs/0e6176a6-ff23-42fd-b998-4039bbbf7691?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Ear/eye/nasal drops, solution",
"routes": [
"Ocular use"
],
"source": "hpra",
"atc_all": [
"S02BA",
"S02BA07"
],
"strength": null,
"pa_number": "PA1638/001/001",
"substances": [
"BETAMETHASONE SODIUM PHOSPHATE"
],
"legal_basis": "Informed consent application (Article 10c of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "01/04/1978",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about betamethasone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.